Exchange Traded Concepts, LLC Acadia Pharmaceuticals Inc Transaction History
Exchange Traded Concepts, LLC
- $7.62 Billion
- Q2 2025
A detailed history of Exchange Traded Concepts, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 1,926 shares of ACAD stock, worth $45,530. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,926
Previous 1,776
8.45%
Holding current value
$45,530
Previous $29,000
41.38%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ACAD
# of Institutions
351Shares Held
163MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$1.01 Billion8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$359 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$285 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$202 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$165 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.83B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...